Vyepti
Provider 
Founded 1915
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public

Vyepti (eptinezumab-jjmr) is Lundbeck's intravenous CGRP monoclonal antibody indicated for the preventive treatment of migraine in adults.
Vyepti is Lundbeck's eptinezumab-jjmr, a monoclonal antibody against CGRP delivered by intravenous infusion for the preventive treatment of migraine in adults; its official site directs patients and providers to treatment information.
Like the subcutaneous CGRP antibodies, it is a marketed migraine-preventive therapy in the class AgoneX Biopharmaceuticals' AGX-201 program positions itself against.
| Attribute | Vyepti | AGX-201 | |
|---|---|---|---|
| Provider | |||
| Founded | 1915 | 2011 | |
| Sells To | Enterprise | Enterprise | |
| Pricing Model | Recurring, Software | Recurring, Software | |
| Ownership | Public | Private |
Provider 
Founded 1915
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public
Provider 
Founded 2011
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Private


Ajovy (fremanezumab-vfrm) is Teva's subcutaneous CGRP monoclonal antibody indicated for the preventive treatment of migraine in adults.

Ajovy (fremanezumab-vfrm) is Teva's subcutaneous CGRP monoclonal antibody indicated for the preventive treatment of migraine in adults.

Emgality (galcanezumab-gnlm) is Eli Lilly's subcutaneous CGRP monoclonal antibody indicated for the preventive treatment of migraine in adults.
Emgality (galcanezumab-gnlm) is Eli Lilly's subcutaneous CGRP monoclonal antibody indicated for the preventive treatment of migraine in adults.



VYVGART Hytrulo is argenx's subcutaneous FcRn-blocking therapy for adults with generalized myasthenia gravis and CIDP.


Nurtec ODT is a Pfizer oral gepant for acute migraine treatment and episodic migraine prevention.
Ubrelvy is an AbbVie oral gepant for the acute treatment of migraine.

Qulipta (atogepant) is AbbVie's once-daily oral CGRP receptor antagonist indicated for the preventive treatment of migraine in adults.

VYVGART Hytrulo is argenx's subcutaneous FcRn-blocking therapy for adults with generalized myasthenia gravis and CIDP.

Nurtec ODT is a Pfizer oral gepant for acute migraine treatment and episodic migraine prevention.
